Coronavirus disease 2019 (COVID-19) results from infection by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It was first reported in Wuhan, China in patients …

Abstract Purpose of Review To describe a comprehensive review of the epidemiology,
pathophysiology, and treatment of stroke in the era of COVID-19. Recent Findings COVID-19 …

BACKGROUND: The mechanisms and outcomes in coronavirus disease (COVID-19)–
associated stroke are unique from those of non–COVID-19 stroke. OBJECTIVE: To describe …

Introduction. The World Health Organization declared COVID‐19 a global pandemic last
year. While a clear impact of COVID‐19 on the declining stroke volume has been reported …

Objective To review the global impact of the COVID‐19 pandemic on stroke care‐metrics
and report data from a health system in Houston. Methods We performed a meta‐analysis of …

Background: Coronavirus disease 2019 (COVID-19) has been shown to associate with
increased risk of thromboembolic events. Mechanical thrombectomy (MT) has long been …

Background Although patients with COVID-19 have a higher risk of acute ischemic stroke
(AIS), the impact on stroke outcomes remains uncertain. Aims To determine the clinical …

Background The coronavirus disease (COVID-19) pandemic has affected stroke care
globally. In this study, we aim to evaluate the impact of the current pandemic on racial …

Background The impact of COVID-19 on clinical outcomes in acute ischemic stroke patients
receiving reperfusion therapy remains unclear. We therefore aimed to synthesize the …

As of May 2022, there have been more than 400 million cases (including re-infections) of the
systemic acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), and nearly 5 million …